nivolumab
bms
['nadim ii', 'nadim']
 dr. will present in the first results of the nadim ii trial that endorse the great benefit of chemo-immunotherapy before operating on early tumours. next 5 june at 5:45 pm. 
GECP/SLCG
Desde 1991 investigando para avanzar en curación y supervivencia al #cancerdepulmon 
#LungResearch #GECPResearch #CancerResearch